Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Martine Bayssas"'
Autor:
Helgi J.K. van de Velde, Xiangyang Liu, Gang Chen, Andrew Cakana, William Deraedt, Martine Bayssas
Publikováno v:
Haematologica, Vol 92, Iss 10 (2007)
There are a number of reports in literature data on the long-term outcomes of patients with multiple myeloma treated with high-dose therapy and autologous stem cell transplantation (HDT/SCT). While in general these data support the association betwee
Externí odkaz:
https://doaj.org/article/f7399e5198104bdbad437130bbecb23a
Autor:
Martine Bayssas, A Strada, S Galbiati, E Donzelli, Maria Grazia Petruccioli, Maria Carfì, Guido Cavaletti, Giovanni Tredici, Genevieve Griffon-Etienne, Mariarosaria Miloso
Publikováno v:
Journal of Neuro-Oncology. 67:65-73
The main dose-limiting side effect of cancer treatment with platinum compounds is peripheral neurotoxicity. To investigate the intracellular mechanisms of platinum drugs neurotoxicity we have studied the effects of cisplatin and oxaliplatin on the hu
Autor:
Jacques Robert, Delphine Meynard, Marie-Christine Haaz, Antoine Vekris, Martine Bayssas, Jacques Bonnet
Publikováno v:
Cancer Research. 64:356-362
Gene expression profiling of tumors allows the establishment of relationships between gene expression profiles and sensitivity to anticancer drugs. In an attempt to study the molecular determinants of the activity of platinum compounds, we explored t
Autor:
William Deraedt, Xiangyang Liu, Andrew Cakana, Helgi van de Velde, Gang Chen, Martine Bayssas
Publikováno v:
Haematologica. 92(10)
There are a number of reports in literature data on the long-term outcomes of patients with multiple myeloma treated with high-dose therapy and autologous stem cell transplantation (HDT/SCT). While in general these data support the association betwee
Autor:
Antoine, Vekris, Delphine, Meynard, Marie-Christine, Haaz, Martine, Bayssas, Jacques, Bonnet, Jacques, Robert
Publikováno v:
Cancer research. 64(1)
Gene expression profiling of tumors allows the establishment of relationships between gene expression profiles and sensitivity to anticancer drugs. In an attempt to study the molecular determinants of the activity of platinum compounds, we explored t
Autor:
May Klink-Alakl, Guy G. Chabot, D Abigerges, Martine Bayssas, Jean-Pierre Armand, G. Catimel, Marie-Christine Bissery, M. Clavel, Ren Bruno
Publikováno v:
Anti-cancer drugs. 7(2)
Intoplicine (RP 60475F; NSC 645008) is a novel 7H-benzo[e]pyrido[4,3-b]indole derivative which interacts with both topoisomerases I and II. Because of its high activity in preclinical cancer models, original mechanism of action and acceptable toxicit
Autor:
A. Setanoians, Martine Bayssas, Craig Lewis, Jim Cassidy, Stanley B. Kaye, Elaine M. Rankin, Lynn Adams, George G. Boder
Publikováno v:
Cancer chemotherapy and pharmacology. 24(4)
LY 195448 is a phenethanolamine that has shown anti-tumour activity in a range of murine tumour models, although its mechanism of action is unknown. Pre-clinical studies have indicated the absence of “standard” side effects such as myelosuppressi